Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Showing news for:APLLTDFinancial Services
Clear all filtersNEWS
positive
Business Standard - Markets 30d ago
Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of Bayer Healthcare Pharmaceuticals Inc. (Bayer).
ALEMBICLTDAPLLTDHCGHCG-REHEALTHCAREMVKAGROFast Moving Consumer GoodsFinancial Services
positive
CNBC TV18 - Markets 57d ago
Alembic Pharma Q4 profit up 29% as US formulations business grows 11%; declares ₹12 dividend
The company also recommended a dividend of ₹12 per equity share of face value ₹2 each for shareholders. Shares of Alembic Pharmaceuticals Ltd ended at ₹782.10, down by ₹4.35, or 0.55%, on the BSE.
ALEMBICLTDAPLLTDBSEDIVIDENDMOVALUEVALUEFinancial ServicesHealthcare
neutral
CNBC TV18 - Markets 142d ago
Alembic Pharma completes USFDA inspection at Karakhadi, Gujarat facility with two observations
Shares of Alembic Pharmaceuticals Ltd ended at ₹773.70, down by ₹2.70, or 0.35%, on the BSE.
ALEMBICLTDAPLLTDBSEFinancial ServicesHealthcare